Becton Dickinson
BDX stock analysis · Health Care · Health Care Equipment
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗Reviewed debt balance
Reviewed consolidated balance-sheet debt: current debt 1560000000 plus noncurrent debt 17621000000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period. Read the financial statement ↗
DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -1.6% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
14 industry peers · median 28.3×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 24.6× · -35.7% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · parent-equity fallback (scope limitation)
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Requires reported dividends, repurchases and issuance; missing values are not zero.
How this is calculated ↗Accrual quality
Parent-earnings fallback versus consolidated cash flow · scope limitation
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $186.74 | $203.75 | $222.04 |
| 10.0% | $136.84 | $148.88 | $161.81 |
| 12.0% | $107.96 | $117.14 | $126.99 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-09-30 | 21.8B | 1.7B | 3.4B | 760M | 55.3B |
| 2024-09-30 | 20.2B | 1.7B | 3.8B | 725M | 57.3B |
| 2023-09-30 | 19.4B | 1.5B | 3B | 874M | 52.8B |
| 2022-09-30 | 18.9B | 1.8B | 2.5B | 973M | 52.9B |
| 2021-09-30 | 19.1B | 2.1B | 4.6B | 1.2B | 53.9B |
| 2020-09-30 | 16.1B | 874M | 3.5B | 769M | 54B |
| 2019-09-30 | 17.3B | 1.2B | 3.3B | 957M | 51.8B |
| 2018-09-30 | 16B | 311M | 2.9B | 895M | 53.9B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 21.8B | Revenues | 2025-11-25 |
| netIncome | 1.7B | NetIncomeLoss Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2025-11-25 |
| Parent/common earnings proxy | 1.7B | NetIncomeLossAvailableToCommonStockholdersBasic | 2025-11-25 |
| cfo | 3.4B | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | 2025-11-25 |
| capex | 760M | PaymentsToAcquirePropertyPlantAndEquipment | 2025-11-25 |
| operatingIncome | 2.6B | OperatingIncomeLoss | 2025-11-25 |
| assets | 55.3B | Assets | 2025-11-25 |
| equity | 25.4B | StockholdersEquity Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2025-11-25 |
| Parent book equity proxy | 25.4B | StockholdersEquity | 2025-11-25 |
| debt | 19.2B | Reviewed manual correction Reviewed consolidated balance-sheet debt: current debt 1560000000 plus noncurrent debt 17621000000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period. | 2025-11-25 |
| shortDebt | — | Not reported under a supported tag | — |
| cash | 641M | CashAndCashEquivalentsAtCarryingValue | 2025-11-25 |
| shares | 288.5M | WeightedAverageNumberOfDilutedSharesOutstanding | 2025-11-25 |
| dividends | 1.2B | PaymentsOfDividendsCommonStock | 2025-11-25 |
| buybacks | 1B | PaymentsForRepurchaseOfCommonStock | 2025-11-25 |
| issuance | — | Not reported under a supported tag | — |